Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 74% ± 14% | |
lung | 19 studies | 60% ± 17% | |
intestine | 13 studies | 46% ± 16% | |
kidney | 9 studies | 56% ± 17% | |
brain | 9 studies | 41% ± 19% | |
eye | 7 studies | 26% ± 11% | |
lymph node | 6 studies | 68% ± 21% | |
liver | 6 studies | 58% ± 20% | |
bone marrow | 5 studies | 56% ± 20% | |
uterus | 5 studies | 58% ± 25% | |
pancreas | 4 studies | 57% ± 23% | |
placenta | 4 studies | 77% ± 19% | |
prostate | 4 studies | 41% ± 8% | |
breast | 4 studies | 54% ± 8% | |
heart | 3 studies | 27% ± 11% | |
adipose | 3 studies | 38% ± 21% | |
adrenal gland | 3 studies | 60% ± 16% | |
esophagus | 3 studies | 59% ± 26% | |
skin | 3 studies | 35% ± 12% | |
thymus | 3 studies | 72% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 8126.40 | 258 / 258 | 100% | 131.44 | 230 / 230 |
esophagus | 100% | 8614.60 | 1445 / 1445 | 100% | 140.71 | 183 / 183 |
kidney | 100% | 8060.52 | 89 / 89 | 100% | 145.46 | 901 / 901 |
lung | 100% | 9918.06 | 578 / 578 | 100% | 182.62 | 1155 / 1155 |
ovary | 100% | 4342.32 | 180 / 180 | 100% | 148.70 | 430 / 430 |
uterus | 100% | 5392.91 | 170 / 170 | 100% | 208.13 | 459 / 459 |
skin | 100% | 8292.51 | 1808 / 1809 | 100% | 131.38 | 472 / 472 |
thymus | 100% | 6150.53 | 653 / 653 | 100% | 170.11 | 604 / 605 |
prostate | 100% | 6362.71 | 245 / 245 | 100% | 154.94 | 501 / 502 |
bladder | 100% | 7031.38 | 21 / 21 | 100% | 221.26 | 502 / 504 |
liver | 100% | 4120.00 | 225 / 226 | 100% | 112.73 | 406 / 406 |
breast | 100% | 7486.18 | 459 / 459 | 100% | 187.31 | 1113 / 1118 |
brain | 100% | 5433.39 | 2630 / 2642 | 100% | 119.85 | 705 / 705 |
stomach | 100% | 6210.84 | 359 / 359 | 99% | 160.74 | 284 / 286 |
intestine | 100% | 7746.78 | 966 / 966 | 99% | 178.23 | 522 / 527 |
pancreas | 99% | 4076.97 | 325 / 328 | 99% | 181.85 | 177 / 178 |
adipose | 100% | 8023.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 395.96 | 29 / 29 |
spleen | 100% | 15149.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 179.78 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 235.03 | 1 / 1 |
peripheral blood | 100% | 19297.57 | 927 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7456.94 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 3596.02 | 830 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 93.84 | 77 / 80 |
muscle | 88% | 2500.91 | 709 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034314 | Biological process | Arp2/3 complex-mediated actin nucleation |
GO_1990090 | Biological process | cellular response to nerve growth factor stimulus |
GO_0030833 | Biological process | regulation of actin filament polymerization |
GO_0070358 | Biological process | actin polymerization-dependent cell motility |
GO_0061850 | Cellular component | growth cone leading edge |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005885 | Cellular component | Arp2/3 protein complex |
GO_0005829 | Cellular component | cytosol |
GO_0030027 | Cellular component | lamellipodium |
GO_0031941 | Cellular component | filamentous actin |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005925 | Cellular component | focal adhesion |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ARPC3 |
Protein name | Actin-related protein 2/3 complex subunit 3 Actin related protein 2/3 complex subunit 3 Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC) |
Synonyms | ARC21 |
Description | FUNCTION: Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) . The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility . In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA . The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) . . FUNCTION: Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. . |
Accessions | F8VR50 ENST00000547365.1 ENST00000228825.12 ENST00000426440.5 Q2LE71 C9JZD1 O15145 |